Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · Real-Time Price · USD
6.38
-0.23 (-3.48%)
At close: May 14, 2025, 4:00 PM
6.31
-0.07 (-1.10%)
After-hours: May 14, 2025, 6:49 PM EDT
Sage Therapeutics Employees
Sage Therapeutics had 353 employees as of December 31, 2024. The number of employees decreased by 134 or -27.52% compared to the previous year.
Employees
353
Change (1Y)
-134
Growth (1Y)
-27.52%
Revenue / Employee
$134,289
Profits / Employee
-$1,003,958
Market Cap
399.52M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SAGE News
- 1 day ago - Sage Therapeutics, Inc. (SAGE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 3 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sage Therapeutics, Inc. (SAGE) and Encourages Stockholders to Learn More About the Investigation - Accesswire
- 6 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Sage Therapeutics, Inc. (SAGE) Investors to Inquire about Securities Investigation - Accesswire
- 8 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sage Therapeutics, Inc. (SAGE) And Encourages Shareholders to Reach Out - Accesswire
- 10 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sage Therapeutics, Inc. (SAGE) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 13 days ago - Sage Therapeutics, Inc. (SAGE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 15 days ago - Sage Therapeutics, Inc. (SAGE) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Sage Therapeutics Announces First Quarter 2025 Financial Results and Highlights Pipeline and Business Updates - Business Wire